Inclusion Criteria:  Written informed consent Previously included in the VP-C21-006 trial and received at least one dose of investigational medicinal product (IMP) Available record of at least one HRCT performed within 24 weeks after completion of VP-C21-006.  Exclusion Criteria:  Participation in another interventional trial during the historical period covered by this study that could interfere with the study objectives or evaluation